Natera Total Liabilities and Share Holders Equity 2014-2024 | NTRA

Natera total liabilities and share holders equity from 2014 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Natera total liabilities and share holders equity for the quarter ending September 30, 2024 was $1.591B, a 9.98% increase year-over-year.
  • Natera total liabilities and share holders equity for 2023 was $1.442B, a 3.39% increase from 2022.
  • Natera total liabilities and share holders equity for 2022 was $1.394B, a 12.78% increase from 2021.
  • Natera total liabilities and share holders equity for 2021 was $1.236B, a 32.65% increase from 2020.
Natera Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $1,442
2022 $1,394
2021 $1,236
2020 $932
2019 $583
2018 $268
2017 $215
2016 $211
2015 $265
2014 $124
2013 $60
Natera Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $1,591
2024-06-30 $1,517
2024-03-31 $1,468
2023-12-31 $1,442
2023-09-30 $1,447
2023-06-30 $1,248
2023-03-31 $1,319
2022-12-31 $1,394
2022-09-30 $1,009
2022-06-30 $1,067
2022-03-31 $1,145
2021-12-31 $1,236
2021-09-30 $1,311
2021-06-30 $850
2021-03-31 $894
2020-12-31 $932
2020-09-30 $977
2020-06-30 $723
2020-03-31 $559
2019-12-31 $583
2019-09-30 $380
2019-06-30 $383
2019-03-31 $261
2018-12-31 $268
2018-09-30 $277
2018-06-30 $194
2018-03-31 $219
2017-12-31 $215
2017-09-30 $204
2017-06-30 $158
2017-03-31 $176
2016-12-31 $211
2016-09-30 $242
2016-06-30 $261
2016-03-31 $266
2015-12-31 $265
2015-09-30 $262
2015-06-30 $107
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30 $0
2013-12-31 $60
Sector Industry Market Cap Revenue
Medical Medical Services $21.401B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00